Mono Pharmacare IPO GMP Details
![Mono pharmacare ipo gmp details 1 Mono pharmacare ipo gmp details with gmpipo. Com](https://www.gmpipo.com/wp-content/uploads/Mono-Pharmacare-IPO-GMP-Details-with-gmpipo.com_.png)
Mono Pharma care Limited, Established in 1994, is actively involved in the marketing and distribution of pharmaceutical products.
The company’s offerings encompass an array of healthcare products, including antibiotics, medicines for coughs, colds, and allergies, antifungal medicines, nutraceutical products, analgesics, antipyretics, antacids, antiemetic medicines, as well as medications for cardiac and diabetic conditions. Additionally, the company provides a range of cosmocare products.
Mono Pharmacare collaborates with contract manufacturers to produce pharmaceutical items, marketing them under their distinctive brand name, DLS Export. In a strategic move to broaden its product spectrum in specific therapeutic domains, the company acquired DLS Export in 2022 for a cumulative sum of ₹609 lakhs.
As of February 28, 2023, Mono Pharmacare boasts a network of over 168 pharmaceutical firms acting as distributors and stockists. The company’s services have extended to more than 3,036 customers and vendors, comprising a mix of retail pharmacy outlets and wholesalers.
Objects of the Issue
The company aims to allocate the net proceeds from the issue to the following objectives:
- Fulfilling the working capital necessities,
- Catering to general corporate endeavors, and
- Covering the expenses related to the issue.
Mono Pharmacare IPO Details
The Mono Pharmacare IPO is a Book Built Issue with a total issue size of ₹14.84 Crores. The IPO price for Mono Pharmacare is set at ₹26 to ₹28 per share. The IPO is set to be listed on the NSE SME platform.
IPO Date | Aug 28, 2023 to Aug 30, 2023 |
Listing Date | Thursday, 7 September 2023 |
Face Value | ₹10 per share |
Price | ₹26 to ₹28 per share |
Lot Size | 4000 Shares |
Total Issue Size | 5,300,000 shares (aggregating up to ₹14.84 Cr) |
Fresh Issue | 5,300,000 shares (aggregating up to ₹[.] Cr) |
Issue Type | Book Built Issue IPO |
Listing At | NSE SME |
Share holding pre issue | 12,368,564 |
Share holding post issue | 17,668,564 |
Market Maker portion | 276,000 shares |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Mono Pharmacare IPO Reservation
QIB Shares Offered | Not more than 10.00% of the Net offer |
NII (HNI) Shares Offered | Not less than 45.00% of the Offer |
Retail Shares Offered | Not less than 45.00% of the Offer |
Mono Pharmacare IPO Lot Size
For the Mono Pharmacare IPO, the minimum lot size is 4,000 shares, requiring an investment of ₹112,000.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 4000 | ₹112,000 |
Retail (Max) | 1 | 4000 | ₹112,000 |
HNI (Min) | 2 | 8,000 | ₹224,000 |
Mono Pharmacare IPO Dates
Mono Pharmacare IPO opens on Aug 28, 2023, and closes on Aug 30, 2023.
IPO Open Date | Monday, 28 August 2023 |
IPO Close Date | Wednesday, 30 August 2023 |
Basis of Allotment | Monday, 4 September 2023 |
Initiation of Refunds | Tuesday, 5 September 2023 |
Credit of Shares to Demat | Wednesday, 6 September 2023 |
Listing Date | Thursday, 7 September 2023 |
Cut-off time for UPI mandate confirmation | 5 PM on Aug 30, 2023 |
Mono Pharmacare Limited Financial Report
Period Ended | 31 Mar 2020 | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
---|---|---|---|---|
Assets | 871.70 | 1,122.46 | 1,438.31 | 6,257.39 |
Revenue | 1,168.90 | 2,837.83 | 3,710.27 | 3,314.77 |
Profit After Tax | 1.99 | 9.51 | 35.09 | 94.53 |
Net Worth | 201.92 | 369.58 | 427.57 | 1,368.57 |
Reserves and Surplus | – | – | – | 131.71 |
Total Borrowing | 633.46 | 608.03 | 643.93 | – |
Key Performance Indicator of Mono Pharmacare Ltd IPO
KPI | Values |
---|---|
ROE | 9.01% |
ROCE | 10.34% |
Debt/Equity | 2.92 |
EPS (Rs) | 1.99 |
RoNW | 9.01% |
Mono Pharmacare IPO Promoter Holding
Panilam Lakhatariya and Supal Lakhatariya are the company’s promoters.
Pre Issue Share Holding | 81.02% |
Post Issue Share Holding | – |
Mono Pharmacare Contact Information
Mono Pharmacare Limited
1A, Krinkal Apartment Opp.
Mahalaxmi Temple, Paldi, Ahmedabad -380007
Phone: +91 99780 41356
Email: cs@monopharmacareltd.com
Website: https://monopharmacareltd.com/
Mono Pharmacare IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
Mono Pharmacare IPO FAQs
What is Mono Pharmacare IPO?
Mono Pharmacare IPO is a SME IPO consisting of 5,300,000 equity shares with a face value of ₹10, aggregating up to ₹14.84 Crores. The issue price ranges from ₹26 to ₹28 per share. The minimum order quantity is 4000 Shares.
The shares are proposed to be listed on NSE SME.
When does Mono Pharmacare IPO open and close?
The Mono Pharmacare IPO opens on August 28, 2023, and closes on August 30, 2023.
How can I apply for Mono Pharmacare IPO through Zerodha?
Zerodha customers can apply online for Mono Pharmacare IPO using UPI as a payment gateway. To apply, login to Zerodha Console (back office), go to Portfolio, click the IPOs link, select ‘Mono Pharmacare IPO’ row, and click the ‘Bid’ button. Enter UPI ID, Quantity, and Price, then ‘Submit’ the IPO application form. Approve the mandate in the UPI App (net banking or BHIM).
What is the lot size of Mono Pharmacare IPO?
The Mono Pharmacare IPO lot size is 4000 Shares, requiring a minimum amount of ₹112,000.
How can I apply for Mono Pharmacare IPO?
You can apply for Mono Pharmacare IPO online using UPI or ASBA as the payment method. ASBA IPO application is available in your bank’s net banking. UPI IPO application is offered by brokers without banking services.
When will Mono Pharmacare IPO allotment be done?
The finalization of Basis of Allotment for Mono Pharmacare IPO will occur on Monday, September 4, 2023. The allotted shares will be credited to your demat account by Wednesday, September 6, 2023.
When is Mono Pharmacare IPO listing date?
The Mono Pharmacare IPO listing date is yet to be announced. The tentative date for Mono Pharmacare IPO listing is Thursday, September 7, 2023.